Analysis: Hormone prescriptions plunged after cancer report

01/7/2004 | NYTimes.com

In the year after July 2002, when it was announced that estrogen-progestin hormone pills posed an increased risk of breast cancer, heart disease and other illnesses in post-menopausal women, the number of prescriptions for hormone supplements plunged by more than one-third, according to a study published in the Journal of the American Medical Association. The study estimated 2003 prescriptions for hormone treatments would total 57 million, compared with 91 million in 2001, before the risk study was published.

View Full Article in:

NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN